mirtazapine has been researched along with Cardiovascular Diseases in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Notably, noradrenergic and specific serotonergic antidepressant (mirtazapine) use was significantly associated with higher prevalence of heart failure (OR 3." | 3.79 | Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population. ( Acharya, S; Acharya, T; Huang, J; Tringali, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, T | 1 |
| Acharya, S | 1 |
| Tringali, S | 1 |
| Huang, J | 1 |
| de Jonge, P | 1 |
| Honig, A | 1 |
| van Melle, JP | 1 |
| Schene, AH | 1 |
| Kuyper, AM | 1 |
| Tulner, D | 1 |
| Schins, A | 1 |
| Ormel, J | 1 |
1 trial available for mirtazapine and Cardiovascular Diseases
| Article | Year |
|---|---|
Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events.
Topics: Antidepressive Agents; Cardiovascular Diseases; Cause of Death; Citalopram; Comorbidity; Depressive | 2007 |
1 other study available for mirtazapine and Cardiovascular Diseases
| Article | Year |
|---|---|
Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Cardiovascular Diseases; Cross-Sectional S | 2013 |